Page last updated: 2024-09-04

atrasentan and omega-n-methylarginine

atrasentan has been researched along with omega-n-methylarginine in 1 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010) (omega-n-methylarginine)
358411084,411344336

Protein Interaction Comparison

ProteinTaxonomyatrasentan (IC50)omega-n-methylarginine (IC50)
Neutrophil elastaseHomo sapiens (human)0.3
Proteinase-activated receptor 1Homo sapiens (human)0.0018
Nitric oxide synthase, endothelialBos taurus (cattle)7
Nitric oxide synthase, endothelialHomo sapiens (human)2.9489
Nitric oxide synthase, brainHomo sapiens (human)3.3983
Nitric oxide synthase, brain Rattus norvegicus (Norway rat)7.5
Nitric oxide synthase, inducibleMus musculus (house mouse)2.3
Nitric oxide synthase, inducibleHomo sapiens (human)2.9252
Collagenase 3Homo sapiens (human)0.3
Nitric oxide synthase, brainMus musculus (house mouse)4.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lennon, R; Lerman, A; Lerman, LO; Mathew, V; Nelson, RE; Prasad, A; Pumper, GM; Raichlin, E; Reriani, M; Rihal, C1

Trials

1 trial(s) available for atrasentan and omega-n-methylarginine

ArticleYear
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.
    Circulation, 2010, Sep-07, Volume: 122, Issue:10

    Topics: Adult; Atrasentan; Blood Glucose; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Rate; Humans; Kidney; Lipoprotein(a); Male; Microcirculation; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pyrrolidines; Receptor, Endothelin A; Triglycerides; Uric Acid

2010